Chirurgisches Vorgehen bei Speicheldrüsenkarzinomen

Speicheldrüsenkarzinome sind sehr bedrohliche Erkrankungen. Das Überleben der Patienten hängt wesentlich von der Planung und der ausreichenden Erfahrung bei der Resektion ab. Dieser Beitrag gibt Hilfestellungen bei den wichtigsten operativen Entscheidungen. Der Artikel zeigt an Beispielen und anhand von Praxistipps, wie die onkologische Speicheldrüsenchirurgie gelingen kann.

Abstract

Salivary gland carcinomas are very threatening diseases. The patient's survival depends to a large extent on planning and performing the resection. This article provides assistance with the most important surgical decisions. Using illustrative examples and practical tips the article shows how oncological salivary gland surgery can be successful.

Schlüsselwörter

Speicheldrüsenchirurgie - Speicheldrüsenkarzinome - Kopf-Hals-Karzinome - Speicheldrüsen

Keywords

Salivary gland surgery - salivary gland carcinomas - head and neck carcinomas - salivary glands

Publication History

Article published online:
23 June 2021

• Literatur

• 1 Poorten VV, Hart A, Vauterin T. Prognostic index for patients with parotid carcinoma: international external validation in a Belgian-German database. Cancer 2009; et al. 115: 540-550
• 2 Sood S, McGurk M, Vaz F. Management of Salivary Gland Tumours: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 2016; 130: S142-S149 DOI: 10.1017/S0022215116000566. (PMID: 27841127)
• 3 Quer M, Guntinas-Lichius O, Marchal F. Classification of parotidectomies: a proposal of the European Salivary Gland Society. Eur Arch Otorhinolaryngol 2016; et al. 273: 3307-3312 DOI: 10.1007/s00405-016-3916-6. (PMID: 26861548)
• 4 Mantsopoulos K, Koch M, Iro H. Extracapsular dissection as sole therapy for small low-grade malignant tumors of the parotid gland. Laryngoscope 2017; 127: 1804-1807 DOI: 10.1002/lary.26482. (PMID: 28145103)
• 5 Agaimy A, Weichert W. Grading of head and neck neoplasms. Pathologe 2016; 37: 285-292 DOI: 10.1007/s00292-016-0173-9. (PMID: 27342593)
• 6 Garatea-Crelgo J, Gay-Escoda C, Bermejo B. Morphological study of the parotid lymph nodes. J Craniomaxillofac Surg 1993; et al. 21: 207-209 DOI: 10.1016/s1010-5182(05)80483-4. (PMID: 8360354)
• 7 Klussmann JP, Ponert T, Mueller RP. Patterns of lymph node spread and its influence on outcome in resectable parotid cancer. Eur J Surg Oncol 2008; et al. 34: 932-937 DOI: 10.1016/j.ejso.2008.02.004. (PMID: 18358679)
• 8 Guntinas-Lichius O, Silver CE, Thielker J. Management of the facial nerve in parotid cancer: preservation or resection and reconstruction. Eur Arch Otorhinolaryngol 2018; et al. 275: 2615-2626 DOI: 10.1007/s00405-018-5154-6. (PMID: 30267218)
• 9 Mehra S, Morris LG, Shah J. Outcomes of temporal bone resection for locally advanced parotid cancer. Skull base 2011; et al. 21: 389-396 DOI: 10.1055/s-0031-1287682. (PMID: 22547966)
• 10 Grosheva M, Pick C, Granitzka T. Impact of extent of parotidectomy on early and long-term complications: A prospective multicenter cohort trial. Head Neck 2019; et al. 41: 1943-1951 DOI: 10.1002/hed.25651. (PMID: 30633414)
• 11 Liu CC, Jethwa AR, Khariwala SS. Sensitivity, Specificity, and Posttest Probability of Parotid Fine-Needle Aspiration: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg 2016; et al. 154: 9-23 DOI: 10.1177/0194599815607841. (PMID: 26428476)
• 12 Guntinas-Lichius O, Gabriel B, Klussmann JP. Risk of facial palsy and severe Frey's syndrome after conservative parotidectomy for benign disease: analysis of 610 operations. Acta Otolaryngol 2006; 126: 1104-1109 DOI: 10.1080/00016480600672618. (PMID: 16923718)
• 13 Lombardi D, McGurk M, Vander Poorten V. Surgical treatment of salivary malignant tumors. Oral Oncol 2017; et al. 65: 102-113 DOI: 10.1016/j.oraloncology.2016.12.007. (PMID: 28017651)
• 14 Scherl C, Haderlein M, Agaimy A. Outcome and management of rare high-grade “salivary” adenocarcinoma: the important role of adjuvant (chemo)radiotherapy. Strahlenther Onkol 2019; et al. 195: 1050-1059 DOI: 10.1007/s00066-019-01499-6. (PMID: 31350567)
• 15 Scherl C, Kato MG, Erkul E. Outcomes and prognostic factors for parotid acinic cell Carcinoma: A National Cancer Database study of 2362 cases. Oral Oncol 2018; et al. 82: 53-60 DOI: 10.1016/j.oraloncology.2018.05.002. (PMID: 29909902)
• 16 Olsen KD, Moore EJ, Lewis JE. Frozen section pathology for decision making in parotid surgery. JAMA Otolaryngol Head Neck Surg 2013; 139: 1275-1278 DOI: 10.1001/jamaoto.2013.5217. (PMID: 24136579)
• 17 Guntinas-Lichius O, Klussmann JP, Schroeder U. Primary parotid malignoma surgery in patients with normal preoperative facial nerve function: outcome and long-term postoperative facial nerve function. Laryngoscope 2004; et al. 114: 949-956 DOI: 10.1097/00005537-200405000-00032. (PMID: 15126763)
• 18 Camilleri IG, Malata CM, McLean NR. Malignant tumours of the submandibular salivary gland: a 15-year review. Br J Plast Surg 1998; et al. 51: 181-185 DOI: 10.1054/bjps.1996.0210. (PMID: 9664875)
• 19 Rinaldo A, Shaha AR, Pellitteri PK. Management of malignant sublingual salivary gland tumors. Oral Oncol 2004; et al. 40: 2-5 DOI: 10.1016/s1368-8375(03)00104-0. (PMID: 14662408)
• 20 Ramakrishna R, Raza SM, Kupferman M. Adenoid cystic carcinoma of the skull base: results with an aggressive multidisciplinary approach. J Neurosurg 2016; et al. 124: 115-121 DOI: 10.3171/2015.1.JNS142462. (PMID: 26252456)
• 21 Freling N, Crippa F, Maroldi R. Staging and follow-up of high-grade malignant salivary gland tumours: The role of traditional versus functional imaging approaches – A review. Oral Oncol 2016; 60: 157-166 DOI: 10.1016/j.oraloncology.2016.04.016. (PMID: 27236737)
• 22 Sood AJ, Houlton JJ, Nguyen SA. Facial nerve monitoring during parotidectomy: a systematic review and meta-analysis. Otolaryngol Head Neck Surgl 2015; et al. 152: 631-637 DOI: 10.1177/0194599814568779. (PMID: 25628369)